Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meyer Elbaz

Showing results (11-20 of 173) with videos related to

Pageof 18
Sort By:
Therapie|August 22, 2024
Impact of new drug releases on heart failure management and hospitalizations in France: A repeated cross-sectional study between 2014 and 2023Paul Gautier, Cécile Vindis, Meyer Elbaz, et al.
Archives of Cardiovascular Diseases|January 16, 2019
How should we implement the recommendations of the Acute Cardiovascular Care Association in intensive cardiac care units in France?François Roubille, Eric Bonnefoy, Etienne Puymirat, et al.
Drug Safety|April 15, 2025
Investigating Risk of Cancer with Sodium-Glucose Cotransporter 2 Inhibitors: A Disproportionality Analysis in the WHO Global Pharmacovigilance Database Vigibase<sup>®</sup>Paul Gautier, Meyer Elbaz, Frédéric Bouisset, et al.
Archives of Cardiovascular Diseases|November 22, 2024
Drug-induced spontaneous coronary artery dissection: Analysis of the World Health Organization's pharmacovigilance databasePaul Gautier, Charles Khouri, Michel Galinier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 28, 2016
No evidence of genotype-3 hepatitis E virus-induced myocarditisRabah Boudjellil, Meyer Elbaz, Olivier Lairez, et al.
Journal of Molecular and Cellular Cardiology Plus|January 13, 2025
Circulating autophagy regulator Rubicon is linked to increased myocardial infarction riskMarie-Hélène Grazide, Jean-Bernard Ruidavets, Wim Martinet, et al.
Cardiology|March 3, 2024
Association of Circulating Autophagy Proteins ATG5 and Beclin 1 with Acute Myocardial Infarction in a Case-Control StudyMarie-Hélène Grazide, Jean-Bernard Ruidavets, Wim Martinet, et al.
Frontiers in Cardiovascular Medicine|January 22, 2024
Plasma levels of autophagy regulator Rubicon are inversely associated with acute coronary syndromeMarie-Hélène Grazide, Jean-Bernard Ruidavets, Wim Martinet, et al.
International Journal of Cardiovascular Interventions|August 12, 2005
Clinical and angiographic outcome of stenting of unprotected left main coronary artery bifurcation narrowingDidier Carrié, Eric Maupas, Mohamed Hmem, et al.
Cardiology Research and Practice|November 26, 2009
Takotsubo cardiomyopathy in a squash playerMathieu Berry, Jerome Roncalli, Olivier Lairez, et al.
Pageof 18

Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
Therapie|August 22, 2024
Impact of new drug releases on heart failure management and hospitalizations in France: A repeated cross-sectional study between 2014 and 2023Paul Gautier, Cécile Vindis, Meyer Elbaz, et al.
Archives of Cardiovascular Diseases|January 16, 2019
How should we implement the recommendations of the Acute Cardiovascular Care Association in intensive cardiac care units in France?François Roubille, Eric Bonnefoy, Etienne Puymirat, et al.
Drug Safety|April 15, 2025
Investigating Risk of Cancer with Sodium-Glucose Cotransporter 2 Inhibitors: A Disproportionality Analysis in the WHO Global Pharmacovigilance Database Vigibase<sup>®</sup>Paul Gautier, Meyer Elbaz, Frédéric Bouisset, et al.
Archives of Cardiovascular Diseases|November 22, 2024
Drug-induced spontaneous coronary artery dissection: Analysis of the World Health Organization's pharmacovigilance databasePaul Gautier, Charles Khouri, Michel Galinier, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 28, 2016
No evidence of genotype-3 hepatitis E virus-induced myocarditisRabah Boudjellil, Meyer Elbaz, Olivier Lairez, et al.
Journal of Molecular and Cellular Cardiology Plus|January 13, 2025
Circulating autophagy regulator Rubicon is linked to increased myocardial infarction riskMarie-Hélène Grazide, Jean-Bernard Ruidavets, Wim Martinet, et al.
Cardiology|March 3, 2024
Association of Circulating Autophagy Proteins ATG5 and Beclin 1 with Acute Myocardial Infarction in a Case-Control StudyMarie-Hélène Grazide, Jean-Bernard Ruidavets, Wim Martinet, et al.
Frontiers in Cardiovascular Medicine|January 22, 2024
Plasma levels of autophagy regulator Rubicon are inversely associated with acute coronary syndromeMarie-Hélène Grazide, Jean-Bernard Ruidavets, Wim Martinet, et al.
International Journal of Cardiovascular Interventions|August 12, 2005
Clinical and angiographic outcome of stenting of unprotected left main coronary artery bifurcation narrowingDidier Carrié, Eric Maupas, Mohamed Hmem, et al.
Cardiology Research and Practice|November 26, 2009
Takotsubo cardiomyopathy in a squash playerMathieu Berry, Jerome Roncalli, Olivier Lairez, et al.
Pageof 18